The Illinois attorney general wants a federal court to dismiss a lawsuit challenging the state’s generic drug pricing law, refuting an industry group’s claim that the law improperly seeks to regulate commerce outside of Illinois.
The Association for Accessible Medicines, which represents generic and biosimilar manufacturers, “alleges no imminent injury in-fact to any of its members” as a result of the state law prohibiting certain price hikes on generic drugs, Illinois Attorney General Kwame Raoul (D) wrote in a brief filed Friday opposing AAM’s motion for a preliminary injunction on the law.
The brief is the first in this case ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.